Investigating Fitness Interventions in the Elderly (INFINITE)
INFINITE
2 other identifiers
interventional
180
1 country
1
Brief Summary
Aging is associated with declines in aerobic capacity, exercise tolerance, and functional endurance that lead to physical disability and loss of independence. Furthermore, the existing high prevalence of obesity in the elderly is greatly exacerbating these aging-related declines in function. To date, regular exercise is the only known therapy to consistently improve aerobic function, and perhaps delay the onset of disability. Although aerobic exercise training does benefit both aerobic capacity and endurance even in obese persons, some data show that the maximal efficacy of exercise for improving aerobic function is blunted by obesity. In addition, our preliminary data show a potential dose-response benefit of concomitant fat loss on exercise-induced improvements in aerobic function. Thus, combining an exercise intervention with caloric restriction resulting in fat loss may be more efficacious for improving aerobic function than exercise alone in obese elderly, a population at high risk for disability. The purpose of this study is to determine whether the amount of fat loss (achieved through controlled underfeeding) affects the magnitude of improvement in aerobic function (maximal aerobic capacity and endurance) in response to a standardized exercise training stimulus that follows current recommendations for older persons.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable obesity
Started Oct 2009
Longer than P75 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2009
CompletedFirst Submitted
Initial submission to the registry
January 11, 2010
CompletedFirst Posted
Study publicly available on registry
January 14, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2014
CompletedJanuary 20, 2026
July 1, 2018
4.9 years
January 11, 2010
January 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
maximal aerobic capacity (VO2max) and functional endurance (400 m walk time)
assessment visits will take place at baseline and post 5 months intervention
Secondary Outcomes (1)
changes in specific CVD risk factors (inflammatory markers, blood lipids, blood pressure, and glucose tolerance)
baseline and 5-month follow-up
Study Arms (3)
Exercise
ACTIVE COMPARATORAll treatment groups will receive 4d/wk of exercise
Exercise + Diet (-250 kcal/d deficit)
EXPERIMENTALExercise 4d/wk with moderate caloric restriction (-250 kcal/d deficit) designed for low fat loss (EX+Low CR; \~4.5 kg weight loss),
Exercise + Diet (-600 kcal/d deficit)
EXPERIMENTALExercise 4d/wk with intensive caloric restriction (-600 kcal/d deficit) designed for high fat loss (EX+High CR; \~10.9 kg weight loss)
Interventions
Exercise 4d/wk with moderate caloric restriction (-250 kcal/d deficit) designed for low fat loss (EX+Low CR; \~4.5 kg weight loss).
Eligibility Criteria
You may qualify if:
- BMI=30-34.9 kg/m2
- Sedentary for past 6 months (\<30 min, 3 d/wk of exercise, including walking)
- Normal cognitive function (MMSE \>24)
- No contraindications for participation in weight loss or exercise (e.g., severe arthritis or musculoskeletal disorders)
- Able to provide own transportation to study visits and intervention
- No drug abuse or excessive alcohol use (\> 7 drinks/week)
- Not dependent on a cane or walker
You may not qualify if:
- Weight loss or gain (±5%) in past 6 months
- Body weight \>136.4 kg (DXA limit is 300 lbs)
- Smoker (No nicotine within past year)
- Osteoporosis (T-score ≥ -2.5)
- Abnormal kidney function tests
- Insulin-dependent or uncontrolled diabetes
- Uncontrolled hypertension (BP\>200/110 mmHg)
- Hypertriglyceridemia (TG\>400 mg/dl)
- Past or current ischemic heart disease, angina, heart failure, peripheral artery disease, stroke, chronic respiratory disease, uncontrolled endocrine/metabolic disease, neurological or hematological disease, clinically evident edema
- Cancer requiring treatment in past 2 years, except non-melanoma skin cancers
- Severe anemia (Hb\<10 g/100 ml)
- Hip fracture, hip or knee replacement, or spinal surgery in past 6 months
- Regular use of medications that influence study variables (growth/steroid hormones, estrogen, anti-inflammatory, beta blockers, etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wake Forest University
Winston-Salem, North Carolina, United States
Related Publications (1)
Brinkley TE, Leng I, Bailey MJ, Houston DK, Hugenschmidt CE, Nicklas BJ, Hundley WG. Effects of Exercise and Weight Loss on Proximal Aortic Stiffness in Older Adults With Obesity. Circulation. 2021 Aug 31;144(9):684-693. doi: 10.1161/CIRCULATIONAHA.120.051943. Epub 2021 Aug 2.
PMID: 34333991DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 11, 2010
First Posted
January 14, 2010
Study Start
October 1, 2009
Primary Completion
September 1, 2014
Study Completion
September 1, 2014
Last Updated
January 20, 2026
Record last verified: 2018-07